netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Fingolimod found 9 matches
Open monograph to display formulary status BNF Category
  Fingolimod Malignant disease and immunosuppression - Fingolimod - 08.02.04
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section Letter sent to healthcare professionals (Jan 2016): Fingolimod (Gilenya▼): risks related to effects on the immune system (08.02.04)
link in drug section MHRA Drug Safety Update (Apr 2016): Fingolimod (Gilenya▼): risks of progressive multifocal leukoencephalopathy, basal-cell carcinoma, and opportunistic infections (08.02.04)
link in drug section MHRA Drug Safety Update (Dec 2017): Fingolimod (Gilenya▼): new contraindications in relation to cardiac risk (08.02.04)
link in drug section MHRA Drug Safety Update (Dec 2017): Fingolimod (Gilenya▼): updated advice about risk of cancers and serious infections (08.02.04)
link in drug section MHRA Drug Safety Update (Jan 2021): Fingolimod (Gilenya▼): updated advice about the risks of serious liver injury and herpes meningoencephalitis (08.02.04)
link in drug section MHRA Drug Safety Update (Sept 2019): Fingolimod (Gilenya▼): increased risk of congenital malformations; new contraindication during pregnancy and in women of childbearing potential not using effective contraception (08.02.04)
link in drug section NICE TA254: Fingolimod for highly active relapsing remitting multiple sclerosis (08.02.04)

SubSection Titles / notes  
Fingolimod - (08.02.04)

 
netFormulary